Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim L Jansen

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
BMC Medical Informatics and Decision Making|April 8, 2022
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in goutRitch Te Kampe, Annelies Boonen, Tim L Jansen, et al.
Annals of the Rheumatic Diseases|January 16, 2015
Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylasesMaartje C P Cleophas, Tania O Crişan, Heidi Lemmers, et al.
The Lancet. Rheumatology|March 22, 2026
A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trialAnusha Moses, Martijn A H Oude Voshaar, Eva H van Geel, et al.
The Journal of Rheumatology|May 17, 2017
Measuring Disease Exacerbation and Flares in Rheumatoid Arthritis: Comparison of Commonly Used Disease Activity Indices and Individual MeasuresMartijn A H Oude Voshaar, Marjan Ghiti Moghadam, Harald E Vonkeman, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|September 19, 2025
Monosodium urate crystals exposure is associated with limited transcriptional changes in primary human PBMCsValentin Nica, Medeea Badii, Orsolya Gaal, et al.
Clinical Rheumatology|April 20, 2010
International position paper on febuxostatTim L Jansen, Pascal Richette, Fernando Perez-Ruiz, et al.
Osteoarthritis and Cartilage|May 28, 2024
Discovery of calcite as a new pro-inflammatory calcium-containing crystal in human osteoarthritic synovial fluidTom Niessink, Roderick H M J Stassen, Brenda Kischkel, et al.
The Journal of Rheumatology|September 3, 2009
The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritisMarlies Blom, Wietske Kievit, Jaap Fransen, et al.
Arthritis Research & Therapy|March 14, 2020
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to goutRebekah Wrigley, Amanda J Phipps-Green, Ruth K Topless, et al.
The Journal of Rheumatology|September 3, 2011
Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritisMarlies Blom, Wietske Kievit, A Rogier T Donders, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
BMC Medical Informatics and Decision Making|April 8, 2022
Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in goutRitch Te Kampe, Annelies Boonen, Tim L Jansen, et al.
Annals of the Rheumatic Diseases|January 16, 2015
Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylasesMaartje C P Cleophas, Tania O Crişan, Heidi Lemmers, et al.
The Lancet. Rheumatology|March 22, 2026
A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trialAnusha Moses, Martijn A H Oude Voshaar, Eva H van Geel, et al.
The Journal of Rheumatology|May 17, 2017
Measuring Disease Exacerbation and Flares in Rheumatoid Arthritis: Comparison of Commonly Used Disease Activity Indices and Individual MeasuresMartijn A H Oude Voshaar, Marjan Ghiti Moghadam, Harald E Vonkeman, et al.
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne|September 19, 2025
Monosodium urate crystals exposure is associated with limited transcriptional changes in primary human PBMCsValentin Nica, Medeea Badii, Orsolya Gaal, et al.
Clinical Rheumatology|April 20, 2010
International position paper on febuxostatTim L Jansen, Pascal Richette, Fernando Perez-Ruiz, et al.
Osteoarthritis and Cartilage|May 28, 2024
Discovery of calcite as a new pro-inflammatory calcium-containing crystal in human osteoarthritic synovial fluidTom Niessink, Roderick H M J Stassen, Brenda Kischkel, et al.
The Journal of Rheumatology|September 3, 2009
The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritisMarlies Blom, Wietske Kievit, Jaap Fransen, et al.
Arthritis Research & Therapy|March 14, 2020
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to goutRebekah Wrigley, Amanda J Phipps-Green, Ruth K Topless, et al.
The Journal of Rheumatology|September 3, 2011
Effectiveness of a third tumor necrosis factor-α-blocking agent compared with rituximab after failure of 2 TNF-blocking agents in rheumatoid arthritisMarlies Blom, Wietske Kievit, A Rogier T Donders, et al.
Pageof 9